BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 25643156)

  • 1. Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization.
    Caldwell AS; Eid S; Kay CR; Jimenez M; McMahon AC; Desai R; Allan CM; Smith JT; Handelsman DJ; Walters KA
    Endocrinology; 2015 Apr; 156(4):1441-52. PubMed ID: 25643156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model.
    Xiong T; Rodriguez Paris V; Edwards MC; Hu Y; Cochran BJ; Rye KA; Ledger WL; Padmanabhan V; Handelsman DJ; Gilchrist RB; Walters KA
    Am J Physiol Endocrinol Metab; 2022 Aug; 323(2):E145-E158. PubMed ID: 35658542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome.
    Caldwell ASL; Edwards MC; Desai R; Jimenez M; Gilchrist RB; Handelsman DJ; Walters KA
    Proc Natl Acad Sci U S A; 2017 Apr; 114(16):E3334-E3343. PubMed ID: 28320971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model.
    Aflatounian A; Edwards MC; Rodriguez Paris V; Bertoldo MJ; Desai R; Gilchrist RB; Ledger WL; Handelsman DJ; Walters KA
    J Endocrinol; 2020 Jun; 245(3):381-395. PubMed ID: 32229702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen Action in Adipose Tissue and the Brain are Key Mediators in the Development of PCOS Traits in a Mouse Model.
    Cox MJ; Edwards MC; Rodriguez Paris V; Aflatounian A; Ledger WL; Gilchrist RB; Padmanabhan V; Handelsman DJ; Walters KA
    Endocrinology; 2020 Jul; 161(7):. PubMed ID: 32301482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.
    Kauffman AS; Thackray VG; Ryan GE; Tolson KP; Glidewell-Kenney CA; Semaan SJ; Poling MC; Iwata N; Breen KM; Duleba AJ; Stener-Victorin E; Shimasaki S; Webster NJ; Mellon PL
    Biol Reprod; 2015 Sep; 93(3):69. PubMed ID: 26203175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic kiss1 mRNA and kisspeptin immunoreactivity are reduced in a rat model of polycystic ovary syndrome (PCOS).
    Brown RE; Wilkinson DA; Imran SA; Caraty A; Wilkinson M
    Brain Res; 2012 Jul; 1467():1-9. PubMed ID: 22668987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of Androgen Receptors From Kisspeptin Neurons Prevents PCOS Features in a Letrozole Mouse Model.
    Decourt C; Watanabe Y; Evans MC; Inglis MA; Fisher LC; Jasoni CL; Campbell RE; Anderson GM
    Endocrinology; 2023 Apr; 164(6):. PubMed ID: 37191144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurokinin 3 Receptor Antagonism Ameliorates Key Metabolic Features in a Hyperandrogenic PCOS Mouse Model.
    Sucquart IE; Nagarkar R; Edwards MC; Rodriguez Paris V; Aflatounian A; Bertoldo MJ; Campbell RE; Gilchrist RB; Begg DP; Handelsman DJ; Padmanabhan V; Anderson RA; Walters KA
    Endocrinology; 2021 May; 162(5):. PubMed ID: 33522579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing the neuroendocrine and ovarian defects of androgen receptor-knockout female mice.
    Cheng XB; Jimenez M; Desai R; Middleton LJ; Joseph SR; Ning G; Allan CM; Smith JT; Handelsman DJ; Walters KA
    Am J Physiol Endocrinol Metab; 2013 Sep; 305(6):E717-26. PubMed ID: 23880317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS.
    Silva MS; Prescott M; Campbell RE
    JCI Insight; 2018 Apr; 3(7):. PubMed ID: 29618656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology.
    Krishnan A; Muthusami S; Periyasamy L; Stanley JA; Gopalakrishnan V; Ramachandran I
    Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32120970
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic androgen excess in female mice does not impact luteinizing hormone pulse frequency or putative GABAergic inputs to GnRH neurons.
    Coyle CS; Prescott M; Handelsman DJ; Walters KA; Campbell RE
    J Neuroendocrinol; 2022 Apr; 34(4):e13110. PubMed ID: 35267218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance.
    Zhang Y; Hu M; Yang F; Zhang Y; Ma S; Zhang D; Wang X; Sferruzzi-Perri AN; Wu X; Brännström M; Shao LR; Billig H
    J Mol Med (Berl); 2021 Oct; 99(10):1427-1446. PubMed ID: 34180022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crocetin attenuates DHT-induced polycystic ovary syndrome in mice via revising kisspeptin neurons.
    Hu Q; Jin J; Zhou H; Yu D; Qian W; Zhong Y; Zhang J; Tang C; Liu P; Zhou Y; Wang X; Sheng L
    Biomed Pharmacother; 2018 Nov; 107():1363-1369. PubMed ID: 30257351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
    Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E
    Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin protects against development of metabolic disturbances in a PCOS mouse model.
    Benrick A; Chanclón B; Micallef P; Wu Y; Hadi L; Shelton JM; Stener-Victorin E; Wernstedt Asterholm I
    Proc Natl Acad Sci U S A; 2017 Aug; 114(34):E7187-E7196. PubMed ID: 28790184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polycystic ovary syndrome-associated gene Yap1 is regulated by gonadotropins and sex steroid hormones in hyperandrogenism-induced oligo-ovulation in mouse.
    Ji SY; Liu XM; Li BT; Zhang YL; Liu HB; Zhang YC; Chen ZJ; Liu J; Fan HY
    Mol Hum Reprod; 2017 Oct; 23(10):698-707. PubMed ID: 28961951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome.
    Moore AM; Prescott M; Campbell RE
    Endocrinology; 2013 Feb; 154(2):796-806. PubMed ID: 23254197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.